Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,597 public trials 1,043 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Study of DF6215 in Patients With Advanced Solid Tumors

NCT06108479

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +42 more
Locations
  • The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States
  • University of California Irvine Medical Center Orange, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 21 locations
View Trial Details
Completed

Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

NCT04539327

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Hospital Torrecárdenas Almería, Andalusia, Spain
  • Hospital Universitario Virgen de la Victoria Málaga, Andalusia, Spain
  • Hospital Universitario Virgen del Rocío Seville, Andalusia, Spain
  • Hospital Universitario Nuestra Señora de Valme Seville, Andalusia, Spain
View all 23 locations
View Trial Details
Completed

A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

NCT05198804

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • Arizona Oncology Associates (Wilmot HOPE) - USOR Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • University of Colorado Aurora, Colorado, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
View all 22 locations
View Trial Details
Completed

A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

NCT06894771

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +45 more
Locations
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0301) Hackensack, New Jersey, United States
  • NEXT Oncology ( Site 0300) San Antonio, Texas, United States
  • Princess Margaret Cancer Center ( Site 0101) Toronto, Ontario, Canada
  • Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0102) Québec, Quebec, Canada
View Trial Details
Completed

Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-assisted Coelioscopy

NCT01247779

Conditions
Adnexal Diseases, Cervical Cancer, Endocrine Gland Neoplasms, +19 more
Locations
  • CHU Bordeaux, Hôpital Saint-André Bordeaux, France
  • Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
  • Centre Oscar Lambret Lille, France
  • CHRU Lille, Hôpital Jeanne de Flandres Lille, France
View all 17 locations
View Trial Details
Completed

A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer

NCT04300647

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Arizona Oncology Associates Phoenix, Arizona, United States
  • Kaiser Permanente - Irvine Irvine, California, United States
  • Augusta University Augusta, Georgia, United States
  • Oncology Associates of Oregon, P.C Eugene, Oregon, United States
View all 58 locations
View Trial Details

Related conditions